R & d exempt
Ended Definitive Contract Awarded Last action
- Contract number
- W911QY18C0004
- Awardee
-
Abzyme Therapeutics LLC UEI H2MLEFWV36N6
- Awarding agency
-
ACC Aberdeen Proving Ground
Army Contracting Command, Department of Defense
- Obligated
- $999,998
Award facts
- Contract value 100% obligated
- $999,998.10 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- Funding agency
- Joint PEO Chemical and Biological Defense Acquisition Support Center, Department of Defense
- NAICS code
- 541714 Research and Development in Biotechnology (except Nanobiotechnology)
- Set-aside
- Total Small Business
- Competition
- Full and Open Competition after exclusion of sources · 1 offer Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Pottstown, PA 19464, USA
- Research
- SBIR Program Phase II Action
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Supplemental Agreement for work within scope | $0 | |
| Other Administrative Action | $0 | |
| Exercise an Option | $499,999 | |
| Supplemental Agreement for work within scope | $0 | |
| Original award | $499,999 |
About this award
This is a Small Business Innovation Research (SBIR) Phase II contract awarded by the Department of the Army Acquisition Support Center Joint PEO Chemical and Biological Defense to Abzyme Therapeutics LLC, a minority-owned biopharmaceutical company. The contract, valued at $999,998.10, is for research and development services related to enhancing HIV gp120 protein production using camelid VHH antibodies. The contract is a Firm Fixed Price Definitive Contract, and the place of performance is Pottstown, Pennsylvania. Abzyme Therapeutics LLC has received multiple federal grants from the National Institutes of Health (NIH) to develop novel therapeutics, including for progressive multiple sclerosis and retinal neovascular diseases.
Quick answers
Who was awarded contract W911QY18C0004?
W911QY18C0004 was awarded to Abzyme Therapeutics LLC by ACC Aberdeen Proving Ground (Army Contracting Command) on November 15, 2017.
How much is contract W911QY18C0004 worth?
The government has obligated $999,998 on W911QY18C0004.
Which agency awarded contract W911QY18C0004?
ACC Aberdeen Proving Ground (Army Contracting Command) awarded W911QY18C0004, with funding from Joint PEO Chemical and Biological Defense (Acquisition Support Center).
Was contract W911QY18C0004 competed?
The extent of competition for W911QY18C0004 was full and open competition after exclusion of sources. The government received 1 offer. It was set aside: Total Small Business.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award